Ipilimumab/nivolumabDermatitis, diarrhoea and hepatitis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1753卷 / 1期

关键词：

D O I：

10.1007/s40278-019-62094-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：202 / 202

相关论文

共 50 条

[1] Ipilimumab/nivolumabDermatitis, colitis and hepatitis: case report
[J]. Reactions Weekly, 2021, 1838 (1) : 288 - 288
[2] Ciclosporin/ipilimumab/nivolumabDermatitis and nephrotoxicity: case report
[J]. Reactions Weekly, 2019, 1765 (1) : 104 - 104
[3] Ipilimumab/nivolumabDermatitis, renal toxicity and pancreatitis: case report
[J]. Reactions Weekly, 2021, 1882 (1) : 254 - 254
[4] Ipilimumab/nivolumabDermatitis, transaminitis and thyroid disorders: case report
[J]. Reactions Weekly, 2018, 1712 (1) : 306 - 306
[5] Ipilimumab/nivolumabColitis and diarrhoea: case report
[J]. Reactions Weekly, 2019, 1741 (1) : 142 - 142
[6] Ipilimumab/nivolumabMucositis and diarrhoea: case report
[J]. Reactions Weekly, 2019, 1771 (1) : 178 - 178
[7] Ipilimumab/pembrolizumabGraves' ophthalmopathy and diarrhoea: case report
[J]. Reactions Weekly, 2019, 1737 (1) : 173 - 173
[8] Ipilimumab/nivolumabThrombotic microangiopathy and diarrhoea: case report
[J]. Reactions Weekly, 2021, 1869 (1) : 196 - 196
[9] Ipilimumab/nivolumabColitis, diarrhoea and skin rash: case report
[J]. Reactions Weekly, 2019, 1739 (1) : 158 - 158
[10] Binimetinib/encorafenib/ipilimumab/nivolumabColitis and diarrhoea: case report
[J]. Reactions Weekly, 2023, 1959 (1) : 147 - 147

← 1 2 3 4 5 →